Idexx Stock Pops on Earnings. Pet Health Is Booming.

Idexx Laboratories was the top performer in the on Monday after the veterinary medicine company reported better-than-expected earnings and boosted its full-year outlook. The Westbrook, Maine-based company posted adjusted earnings of $3.22 a share for the third quarter, ahead of analysts’ consensus estimates of $3.12. Idexx stock rose 16% to $729.04, putting it on pace for an all-time closing high, according to Dow Jones Market Data.